| Literature DB >> 30842268 |
Patrick K Taylor1, Li Zhang1, Thien-Fah Mah2.
Abstract
The two-component system TctD-TctE is important for regulating the uptake of tricarboxylic acids in Pseudomonas aeruginosa TctD-TctE accomplishes this through derepression of the gene opdH, which encodes a tricarboxylic acid-specific porin. Previous work from our lab revealed that TctD-TctE in P. aeruginosa also has a role in resistance to aminoglycoside antibiotics. The aim of this study was to further characterize the role of TctD-TctE in P. aeruginosa in the presence of citric acid. Here it was found that deletion of P. aeruginosa PA14 TctD-TctE (ΔtctED) resulted in a 4-fold decrease in the biofilm bactericidal concentrations of the aminoglycosides tobramycin and gentamicin when citric acid was present in nutrient media. Tobramycin accumulation assays demonstrated that deletion of TctD-TctE resulted in an increase in the amount of tobramycin retained in biofilm cells. The PA14 wild type responded to increasing concentrations of citric acid by producing less biofilm. In contrast, the amount of ΔtctED mutant biofilm formation remained constant or enhanced. Furthermore, the ΔtctED strain was incapable of growing on citric acid as a sole carbon source and was highly reduced in its ability to grow in the presence of citric acid even when an additional carbon source was available. Use of phenotypic and genetic microarrays found that this growth deficiency of the ΔtctED mutant is unique to citric acid and that multiple metabolic genes are dysregulated. This work demonstrates that TctD-TctE in P. aeruginosa has a role in biofilm development that is dependent on citric acid and that is separate from the previously characterized involvement in resistance to antibiotics.IMPORTANCE Nutrient availability is an important contributor to the ability of bacteria to establish successful infections in a host. Pseudomonas aeruginosa is an opportunistic pathogen in humans causing infections that are difficult to treat. In part, its success is attributable to a high degree of metabolic versatility. P. aeruginosa is able to sense and respond to varied and limited nutrient stress in the host environment. Two-component systems are important sensors-regulators of cellular responses to environmental stresses, such as those encountered in the host. This work demonstrates that the response by the two-component system TctD-TctE to the presence of citric acid has a role in biofilm formation, aminoglycoside susceptibility, and growth in P. aeruginosa.Entities:
Keywords: Pseudomonas aeruginosa; biofilms; citric acid; two-component regulatory systems
Mesh:
Substances:
Year: 2019 PMID: 30842268 PMCID: PMC6403454 DOI: 10.1128/mSphere.00102-19
Source DB: PubMed Journal: mSphere ISSN: 2379-5042 Impact factor: 4.389
MBCs for antibiotics in medium including 10 mM citric acid
| Culture and strain | MBC (μg/ml) | ||
|---|---|---|---|
| Tobramycin | Gentamicin | Ciprofloxacin | |
| Planktonic | |||
| PA14 | 64 | 128 | 4 |
| Δ | 32 | 64 | 4 |
| Biofilm | |||
| PA14 | 400 | 800 | 40 |
| Δ | 100 | 200 | 40 |
FIG 1Tobramycin accumulation assays of PA14 and the ΔtctED mutant under conditions where citric acid is present during growth of the biofilms. By the disk diffusion assay, disks were loaded with whole-biofilm lysate from cultures grown under conditions where citric acid was present. The results represented by the columns are averages from 3 biological repeats, and error bars are SEMs. The Bonferroni-Dunn method was used to determine significance, *, P < 0.05.
FIG 2Amount of biofilm formation compared between PA14 and the ΔtctED mutant in the presence of added citric acid. Conditions of no tobramycin and tobramycin at a subinhibitory concentration (1 μg/ml) were tested. The results represented by the columns represent the means from 3 biological replicates, and error bars are SEMs. The Bonferroni-Dunn method was used to determine significance. **, P < 0.01; ***, P < 0.001.
FIG 3Phase-contrast microscopy (A) and 0.1% crystal violet staining (B) were used to assess PA14 and ΔtctED mutant biofilm cultures. Biofilms were grown statically in 12-well culture plates using the air-liquid interface assay described in Materials and Methods. Images are representative of those from 30 fields of view for each of 3 biological replicates. Crystal violet staining was performed on the same cultures used for microscopy after images were taken.
FIG 4The ΔtctED strain (Δ) exhibits a reduced ability to grow relative to PA14 (●) when citric acid is present in M63-arginine medium. Concentrations of 0 mM (A), 2 mM (B), 10 mM (C), and 20 mM (D) citric acid were tested with zero, subinhibitory (1 μg/ml), and inhibitory (4 μg/ml) concentrations of tobramycin. The data shown are the averages from 3 biological replicates, where error bars are the standard error of the mean (SEM). Where no error bars are visible, the SEM was less than what could be displayed on the graph.
FIG 5Complementation of the ΔtctED mutant with pJB866 harboring a wild-type copy of tctED (tctED) restored growth on gradient agar plates. PA14 was transformed with pJB866 (PA14 VC [vector control]) to allow growth on selective medium.
Assessment of ΔtctED mutant growth on various carbon sources through use of a phenotype microtiter assay
| Carbon source | Δ |
|---|---|
| α-Hydroxy-butyric acid | − |
| α-Keto-butyric acid | + |
| Adenosine | + |
| Citric acid | − |
| − | |
| Putrescine | + |
| Uridine | + |
Genes with significant changes in expression (>2-fold) in the ΔtctED mutant relative to PA14 grown in planktonic and biofilm cultures
| Culture and gene locus | Gene name | Gene function | Fold change in expression |
|---|---|---|---|
| Planktonic | |||
| PA14_01310 | 4.80 | ||
| PA14_70010 | 4.73 | ||
| | |||
| PA14_60190 | ClpB protein | 3.81 | |
| PA14_07660 | 3.77 | ||
| | |||
| | 3.06 | ||
| PA14_38840 | 2.88 | ||
| PA14_17550 | 2.82 | ||
| PA14_07680 | 2.78 | ||
| PA14_68840 | 2.75 | ||
| PA14_58690 | 2.68 | ||
| PA14_61600 | 2.68 | ||
| PA14_61610 | 2.60 | ||
| PA14_44480 | 2.57 | ||
| PA14_02520 | 2.54 | ||
| PA14_45620 | Two-component response regulator CheY | 2.48 | |
| PA14_17700 | 2.48 | ||
| PA14_10730 | 2.44 | ||
| PA14_24770 | 2.38 | ||
| PA14_68260 | 2.36 | ||
| PA14_45610 | Chemotaxis protein CheZ | 2.29 | |
| PA14_16260 | 2.29 | ||
| | |||
| PA14_61840 | 2.28 | ||
| PA14_60520 | 2.26 | ||
| PA14_16680 | 2.19 | ||
| PA14_30830 | 2.17 | ||
| PA14_44860 | 2.15 | ||
| PA14_71720 | 2.14 | ||
| | |||
| PA14_05060 | 2.06 | ||
| PA14_24760 | 2.05 | ||
| PA14_26590 | 2.04 | ||
| PA14_51850 | 2.01 | ||
| PA14_27210 | Translation elongation factor P | −2.01 | |
| PA14_66140 | −2.01 | ||
| | |||
| PA14_64560 | −2.02 | ||
| PA14_65605 | Topoisomerase IV subunit A | −2.03 | |
| PA14_54370 | GTP-binding protein LepA | −2.04 | |
| PA14_25490 | −2.04 | ||
| PA14_18350 | −2.04 | ||
| | |||
| PA14_61780 | −2.06 | ||
| PA14_17060 | 30S ribosomal protein S2 | −2.09 | |
| | |||
| PA14_51840 | −2.12 | ||
| | |||
| PA14_21760 | Cold acclimation protein B | −2.13 | |
| PA14_65160 | −2.14 | ||
| | |||
| PA14_09030 | 50S ribosomal protein L30 | −2.15 | |
| | |||
| | |||
| PA14_09050 | Secretion protein SecY | −2.18 | |
| PA14_70640 | Rubredoxin 1 | −2.20 | |
| PA14_73420 | Ribonuclease P protein component | −2.20 | |
| PA14_25760 | DNA polymerase III, delta prime subunit | −2.21 | |
| PA14_57580 | 30S ribosomal protein S9 | −2.22 | |
| PA14_09020 | 30S ribosomal protein S5 | −2.23 | |
| PA14_63120 | −2.24 | ||
| PA14_25730 | −2.25 | ||
| PA14_65170 | 30S ribosomal protein S18 | −2.25 | |
| PA14_58130 | Rod shape-determining protein MreC | −2.26 | |
| PA14_41250 | Trigger factor | −2.27 | |
| PA14_08860 | 50S ribosomal protein L4 | −2.30 | |
| PA14_12550 | −2.33 | ||
| PA14_09000 | 50S ribosomal protein L6 | −2.36 | |
| | |||
| PA14_25630 | 50S ribosomal protein L32 | −2.41 | |
| PA14_09010 | 50S ribosomal protein L18 | −2.44 | |
| PA14_00580 | −2.48 | ||
| PA14_07560 | 30S ribosomal protein S21 | −2.48 | |
| PA14_63110 | −2.48 | ||
| PA14_14610 | −2.49 | ||
| PA14_63150 | Two-component regulator system response regulator | −2.49 | |
| | |||
| PA14_61820 | −2.55 | ||
| PA14_09040 | 50S ribosomal protein L15 | −2.58 | |
| PA14_65180 | 30S ribosomal protein S6 | −2.58 | |
| PA14_15980 | 16S rRNA processing protein | −2.59 | |
| PA14_73410 | −2.62 | ||
| PA14_58570 | −2.68 | ||
| PA14_25270 | Aromatic amino acid transport protein AroP1 | −2.76 | |
| | |||
| PA14_58120 | Rod shape-determining protein MreD | −2.91 | |
| PA14_67560 | Regulatory protein TypA | −2.93 | |
| PA14_52340 | −3.04 | ||
| PA14_27370 | −3.52 | ||
| PA14_15970 | 30S ribosomal protein S16 | −3.55 | |
| PA14_70180 | 50S ribosomal protein L33 | −3.59 | |
| PA14_15990 | tRNA (guanine-N1)-methyltransferase | −3.60 | |
| PA14_39060 | −4.14 | ||
| Biofilm | |||
| PA14_72260 | 5.54 | ||
| PA14_02520 | 5.26 | ||
| PA14_42860 | 3.51 | ||
| PA14_46900 | 3.41 | ||
| PA14_56540 | 2.94 | ||
| PA14_55750 | 2.92 | ||
| PA14_22350 | 2.52 | ||
| PA14_56690 | 2.47 | ||
| | |||
| | |||
| PA14_49170 | Two-component sensor PhoQ | 2.11 | |
| | |||
| | |||
| | |||
| PA14_18360 | 2.02 | ||
| | |||
| PA14_47420 | −2.13 | ||
| PA14_55590 | −2.19 | ||
| | |||
| PA14_00990 | −2.22 | ||
| PA14_56980 | −2.23 | ||
| PA14_52070 | −2.24 | ||
| |
Where no gene name is provided, it is an uncharacterized gene with a conserved hypothetical gene product.
Values are the means for 2 biological replicates.
Boldface describes genes involved in metabolism.
Strains and plasmids used in this study
| Strain | Description | Reference or source |
|---|---|---|
| Strains | ||
| PA14 | ||
| Δ | PA14 containing a chromosomal deletion of | |
| PA14 VC | PA14 complemented with pJB866 | |
| Δ | ||
| PA14efflux | PA14 complemented with pJB866::PA1875-1877 | This study |
| Δ | Δ | This study |
| Plasmids | ||
| pJB866 | ||
| pJB866:: | pJB866 carrying a | |
| pJB866::PA1875-1877 | pJB866 carrying PA1875-1877 drug efflux system genes |